NanoVation is an Israeli SME developing and integrating nanomaterial-based sensors for medical applications and general purposes. Thec company is run by an experienced and multi-disciplinary team of 12 people.

NanoVation is about to finalise the development of the SenseGuard device and validate its efficacy and safety in dedicated clinical studies. SenseGuard is a reliable solution for monitoring of patients with respiratory diseases, including COPD, based on a unique nanosensor-based technology. It is an innovative wireless wearable device that enables continuous and non-invasive monitoring of lung functions derived from patients’ tidal (normal) breathing.